Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Moderna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, children

Ruchika Sharma25 Sept 2022 10:30 AM IST

US: Moderna Inc said on Friday it has requested U.S. authorization for use of its Omicron-targeting COVID vaccine in adolescents and children.The...

GSK Nucala application for COPD accepted for review in China

GSK announces USFDA committee to review Zejula overall survival data from NOVA phase III trial in recurrent ovarian cancer

Ruchika Sharma24 Sept 2022 5:41 PM IST

UK: GSK plc has announced that the US Food and Drug Administration (USFDA) will convene a meeting of the Oncologic Drugs Advisory Committee (ODAC) to...

AstraZeneca, Merck get Chinese nod for Lynparza to treat ovarian cancer

Ruchika Sharma24 Sept 2022 3:24 PM IST

In China, Lynparza is approved for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer as well as a 1st-line maintenance...

Need to fast-track regulatory processes for biotech sector: CII Report

Ruchika Sharma24 Sept 2022 12:15 PM IST

"There is a need for autonomy in policy making and implementation," the report released on Friday at the 4th CII Lifesciences Conclave stated.

Cipla gets USFDA EIR for Indore facility

Ruchika Sharma24 Sept 2022 11:07 AM IST

Mumbai: Pharma major, Cipla, has recently announced that the Company has received Establishment Inspection Report (EIR) from the United States Food...

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

Govt approves setting up of Exports Promotion Council for Medical Devices

Ruchika Sharma23 Sept 2022 5:00 PM IST

The new Export Promotion Council (EPC) for medical devices will be set up, with Headquarters in YEIDA, Greater Noida, Uttar Pradesh, and regional...

USFDA nod to Eli Lilly RET Inhibitor Retevmo for adults with advanced or metastatic solid tumors with a RET Gene Fusion, regardless of type

Ruchika Sharma23 Sept 2022 4:20 PM IST

In addition to the tumor-agnostic approval, the USFDA has granted traditional approval for Retevmo in adult patients with locally advanced or...

Aurobindo Pharma US arm gets USFDA EIR for Raleigh facility

Ruchika Sharma23 Sept 2022 2:32 PM IST

Hyderabad: Aurobindo Pharma has recently announced that Aurolife Pharma LLC, a wholly owned step-down subsidiary of the Company has received an...

Shilpa Medicare Hyderabad division gets USFDA clearance

Ruchika Sharma23 Sept 2022 12:15 PM IST

The USFDA clearance on the facility will enable the company to test and release batches into the US from this facility.

Lupin bags USFDA nod for Diclofenac Sodium Topical Solution to treat arthritic knee pain

Ruchika Sharma23 Sept 2022 11:15 AM IST

The product will be manufactured at Lupin's facility in Pithampur, India.

COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO

Ruchika Sharma22 Sept 2022 4:14 PM IST

Both therapies continue to be recommended for use by the European drugs regulator.

Novartis intrathecal onasemnogene abeparvovec Phase III study

Novartis to take US drug patent case to Supreme Court

Ruchika Sharma22 Sept 2022 3:46 PM IST

Zurich: Novartis AG plans to ask the U.S. Supreme court to uphold the validity of a patent it holds on the dosing regimen for multiple sclerosis drug...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok